ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1766

Inflammatory Priming of the Joints via Pre-activation of Macrophages by Anti-MAA Antibodies in Rheumatoid Arthritis

Marcelo Afonso1, Jitong Sun1, Koji Sakuraba1, Anca Catrina1, Aase Hensvold2, Caroline Grönwall1 and Bence Réthi1, 1Karolinska Institutet, Stockholm, Sweden, 2Division of Rheumatology, Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet. Center for Rheumatology, Academic Specialist Center, Stockholm, Sweden

Meeting: ACR Convergence 2023

Keywords: Autoantibody(ies), cytokines, Inflammation, macrophages, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1734–1775) RA – Etiology and Pathogenesis Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: We have previously shown that certain malondialdehyde/acetaldehyde modified protein binding autoantibodies (anti-MAA), obtained from the inflamed joints of rheumatoid arthritis (RA) patients, induced osteoclast differentiation in vitro and bone loss in vivo via an FcγR-mediated mechanism (1). In the present work we studied the effect of these antibodies on joint inflammation and, more specifically, on the function of macrophages.

Methods: We analysed global gene expression, by RNAseq, in the ankle joints of mice injected with patient-derived anti-MAA monoclonal antibodies, in the presence or absence of intraperitoneally injected LPS, which mimicked systemic inflammation. We have also analysed gene expression changes and cytokine production in anti-MAA treated macrophage cultures.

Results: Intravenous injection of anti-MAA antibodies led to subtle changes in the gene expression of the joints, with altered expression of several genes involved in immune responses and cell signalling. Intraperitoneally injected LPS induced robust gene expression changes in the ankles, with several cytokine and other immune mediators expressed at slightly higher level in the anti-MAA pretreated group. Anti-MAA pretreatment could also induce a more inflammatory macrophage phenotype in vitro, in response to a subsequent LPS activation. Similarly to the previously described osteoclast stimulatory effect, the inflammatory priming of macrophages was induced by several but not all of the tested anti-MAA monoclonal antibodies, and the effect was mediated via FcγR-transmitted signals.

Conclusion: Class-switched anti-MAA autoantibodies are typically associated with high disease activity in RA, but such antibodies have also been detected in some of the healthy donors and in individuals at risk of RA (2 and our unpublished data). Our results indicated that certain anti-MAA IgG autoantibody clones may contribute to an inflammatory priming of the joint tissues prior to the onset of systemic inflammation. FcγR-mediated pre-activation of macrophages could play an important role in this effect, by setting the stage for augmented responses to subsequent inflammatory stimuli.

1. Sakuraba et al. J Autoimmun 2022
2. Grönwall et al. Front Immunol 2021


Disclosures: M. Afonso: None; J. Sun: None; K. Sakuraba: None; A. Catrina: None; A. Hensvold: None; C. Grönwall: None; B. Réthi: None.

To cite this abstract in AMA style:

Afonso M, Sun J, Sakuraba K, Catrina A, Hensvold A, Grönwall C, Réthi B. Inflammatory Priming of the Joints via Pre-activation of Macrophages by Anti-MAA Antibodies in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/inflammatory-priming-of-the-joints-via-pre-activation-of-macrophages-by-anti-maa-antibodies-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inflammatory-priming-of-the-joints-via-pre-activation-of-macrophages-by-anti-maa-antibodies-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology